JOURNAL ARTICLE

Study on extraction and characterization of new antibiotics violacein from engineered Escherichia coli VioABCDE‐SD.

  • Published In: Biotechnology & Applied Biochemistry, 2023, v. 70, n. 5. P. 1582 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Huang, Chunyan; Chu, Xiaoting; Hui, Wenyang; Xie, Chengjia; Xu, Xian 3 of 3

Abstract

To better understand the characteristic properties of violacein biosynthesized by engineered Escherichia coli VioABCDE‐SD, a convenient and simplified method was designed to extract violacein and its stability, antimicrobial activity, and antioxidant capacity were analyzed. Different from the traditional extraction methods, our new method is easier and less time consuming and can directly obtain violacein dry powder product with a higher extraction rate. Low temperature, dark condition, neutral pH, reducing agents, Ba2+, Mn2+, Ni2+, Co2+, and some food additives of sucrose, xylose, and glucose were conducive to maintaining its stability. The violacein also exhibited surprisingly high bacteriostatic action against Gram‐positive Bacillus subtilis, Deinococcus radiodurans R1, and Staphylococcus aureus and Gram‐negative Pseudomonas aeruginosa, but no effect on E. coli. The violacein of VioABCDE‐SD exhibited strong antioxidant activity, with the scavenging rate of 1,1‐diphenyl‐2‐picrylhydrazyl free radicals reaching 60.33%, the scavenging efficiency of hydroxyl radical scavenging reaching 56.34%, and the total antioxidant capacity reaching 0.63 U/mL. Violacein from VioABCDE‐SD can be synthesized directionally with better stability, antibacterial, and antioxidant properties compared with that from the original strain Janthinobacterium sp. B9‐8. Therefore, our study indicated that violacein from engineered E. coli VioABCDE‐SD was a kind of new antibiotic with potential biological activities, which may have potential utility in multiple areas such as pharmacological, cosmetics, and healthy food industries. [ABSTRACT FROM AUTHOR]

Additional Information

  • Source:Biotechnology & Applied Biochemistry. 2023/10, Vol. 70, Issue 5, p1582
  • Document Type:Article
  • Subject Area:Pharmacy and Pharmacology
  • Publication Date:2023
  • ISSN:0885-4513
  • DOI:10.1002/bab.2454
  • Accession Number:172894730
  • Copyright Statement:Copyright of Biotechnology & Applied Biochemistry is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.